Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
- 16 April 2002
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 136 (8), 604-615
- https://doi.org/10.7326/0003-4819-136-8-200204160-00010
Abstract
Progression to renal parenchymal damage and end-stage renal disease, which seems to be largely independent of the initial insult, is the final common pathway for chronic, proteinuric nephropathies in animals and humans. The key event is enhanced glomerular capillary pressure; this impairs glomerular permeability to proteins and permits excessive amounts of proteins to reach the lumen of the proximal tubule. The secondary process of reabsorption of filtered proteins can contribute to renal interstitial injury by activating intracellular events, including upregulation of the genes encoding vasoactive and inflammatory mediators. Both interstitial inflammation and progression of disease can be controlled by such drugs as angiotensin-converting enzyme inhibitors, which strengthen the glomerular permeability barrier to proteins and thereby limit proteinuria and filtered protein-dependent inflammatory signals. Clinical data strongly suggest that remission can now be achieved in some patients with chronic renal disease. Because of the current lag time between starting treatment and remission, however, a substantial proportion of patients still progress to end-stage renal disease before renal function begins to stabilize. A multimodal approach that centers on reducing or removing all risk factors associated with the progression of renal disease may decrease the time to remission of the disease for most patients with proteinuric nephropathies.Keywords
This publication has 38 references indexed in Scilit:
- The return of glomerular-filtered albumin to the rat renal veinKidney International, 1999
- Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.Nephron Experimental Nephrology, 1998
- RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial FibrosisThe Journal of Experimental Medicine, 1997
- Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteinsAmerican Journal of Kidney Diseases, 1995
- Renal endothelin gene expression is increased in remnant kidney and correlates with disease progressionKidney International, 1993
- Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis.Circulation Research, 1987
- Role for angiotensin II in an overt functional proteinuriaKidney International, 1986
- Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathyKidney International, 1986
- Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablationAmerican Journal of Physiology-Renal Physiology, 1981
- RELATIONSHIP BETWEEN RENAL FUNCTION AND HISTOLOGICAL CHANGES FOUND IN RENAL-BIOPSY SPECIMENS FROM PATIENTS WITH PERSISTENT GLOMERULAR NEPHRITISThe Lancet, 1968